NASHA hyaluronic acid for the treatment of shoulder osteoarthritis: a prospective, single-arm clinical trial

References

• Thomas M, Bidwai A, Rangan A, et al. Glenohumeral osteoarthritis. Shoulder Elbow. 2016;8(3):203–214. doi:10.1177/175857321664418327583021
   PubMedGoogle Scholar
• Millett PJ, Gobezie R, Boykin RE. Shoulder osteoarthritis: diagnosis and management. Am Fam Physician. 2008;78(5):605–611.18788237
   PubMed Web of Science ®Google Scholar
• Blaine T, Moskowitz R, Udell J, et al. Treatment of persistent shoulder pain with sodium hyaluronate: a randomized, controlled trial. A multicenter study. J Bone Joint Surg Am. 2008;90(5):970–979. doi:10.2106/JBJS.F.0111618451387
   PubMed Web of Science ®Google Scholar
• Di Giacomo G, de Gasperis N. Hyaluronic acid intra-articular injections in patients affected by moderate to severe glenohumeral osteoarthritis: a prospective randomized study. Joints. 2017;5(3):138–142. doi:10.1055/s-0037-160538929270542
   PubMedGoogle Scholar
• Kwon YW, Eisenberg G, Zuckerman JD. Sodium hyaluronate for the treatment of chronic shoulder pain associated with glenohumeral osteoarthritis: a multicenter, randomized, double-blind, placebo-controlled trial. J Shoulder Elbow Surg. 2013;22(5):584–594. doi:10.1016/j.jse.2012.10.04023333168
   PubMed Web of Science ®Google Scholar
• Merolla G, Bianchi P, Porcellini G. Ultrasound-guided subacromial injections of sodium hyaluronate for the management of rotator cuff tendinopathy: a prospective comparative study with rehabilitation therapy. Musculoskelet Surg. 2013;97(Suppl 1):49–56. doi:10.1007/s12306-013-0259-y23605079
   PubMedGoogle Scholar
• Noel E, Hardy P, Hagena FW, et al. Efficacy and safety of Hylan G-F 20 in shoulder osteoarthritis with an intact rotator cuff. Open-label prospective multicenter study. Joint Bone Spine. 2009;76(6):670–673. doi:10.1016/j.jbspin.2009.10.00819945321
   PubMed Web of Science ®Google Scholar
• Porcellini G, Merolla G, Giordan N, et al. Intra-articular glenohumeral injections of HYADD®4-G for the treatment of painful shoulder osteoarthritis: a prospective multicenter, open-label trial. Joints. 2015;3(3):116–121. doi:10.11138/jts/2015.3.3.11626889467
   PubMedGoogle Scholar
• Silverstein E, Leger R, Shea KP. The use of intra-articular hylan G-F 20 in the treatment of symptomatic osteoarthritis of the shoulder: a preliminary study. Am J Sports Med. 2007;35(6):979–985. doi:10.1177/036354650730025617395958
   PubMed Web of Science ®Google Scholar
• Weil AJ. High molecular weight hyaluronan for treatment of chronic shoulder pain associated with glenohumeral arthritis. Med Devices (Auckl). 2011;4:99–105. doi:10.2147/MDER.S2242322915936
   PubMedGoogle Scholar
• Altman RD, Akermark C, Beaulieu AD, Schnitzer T. Durolane International Study G. Efficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee. Osteoarthritis Cartilage. 2004;12(8):642–649. doi:10.1016/j.joca.2004.04.01015262244
   PubMed Web of Science ®Google Scholar
• Arden NK, Akermark C, Andersson M, Todman MG, Altman RD. A randomized saline-controlled trial of NASHA hyaluronic acid for knee osteoarthritis. Curr Med Res Opin. 2014;30(2):279–286. doi:10.1185/03007995.2013.85563124168077
   PubMed Web of Science ®Google Scholar
• Berg P, Olsson U. Intra-articular injection of non-animal stabilised hyaluronic acid (NASHA) for osteoarthritis of the hip: a pilot study. Clin Exp Rheumatol. 2004;22(3):300–306.15144123
   PubMed Web of Science ®Google Scholar
• Conrozier T, Couris CM, Mathieu P, et al. Safety, efficacy and predictive factors of efficacy of a single intra-articular injection of non-animal-stabilized-hyaluronic-acid in the hip joint: results of a standardized follow-up of patients treated for hip osteoarthritis in daily practice. Arch Orthop Trauma Surg. 2009;129(6):843–848. doi:10.1007/s00402-008-0778-419011882
   PubMed Web of Science ®Google Scholar
• Leighton R, Akermark C, Therrien R, et al. NASHA hyaluronic acid vs. methylprednisolone for knee osteoarthritis: a prospective, multi-centre, randomized, non-inferiority trial. Osteoarthritis Cartilage. 2014;22(1):17–25. doi:10.1016/j.joca.2013.10.00924185114
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhang K, Zhang X, et al. Comparison of two hyaluronic acid formulations for safety and efficacy (CHASE) study in knee osteoarthritis: a multicenter, randomized, double-blind, 26-week non-inferiority trial comparing Durolane to Artz. Arthritis Res Ther. 2015;17:51. doi:10.1186/s13075-015-0557-x25889322
   PubMed Web of Science ®Google Scholar
• Smith & Nephew. Advanced hyaluronic acid therapy made available to all European patients recovering from arthroscopic joint surgery. 2010 Available from: http://www.skinequity.com/news-and-media/media-releases/news/advanced-hyaluronic-acid-therapy-made-available-t/. Accessed 10, 2018.
   Google Scholar
• Schulz KF, Altman DG, Moher D. Group C. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332. doi:10.1136/bmj.c29320332509
   PubMed Web of Science ®Google Scholar
• Dworkin RH, Turk DC, Wyrwich KW, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain. 2008;9(2):105–121. doi:10.1016/j.jpain.2007.09.00518055266
   PubMed Web of Science ®Google Scholar
• Ehrich EW, Davies GM, Watson DJ, Bolognese JA, Seidenberg BC, Bellamy N. Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis. J Rheumatol. 2000;27(11):2635–2641.11093446
   PubMed Web of Science ®Google Scholar
• Tubach F, Ravaud P, Baron G, et al. Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement. Ann Rheum Dis. 2005;64(1):29–33. doi:10.1136/ard.2004.02290515208174
   PubMed Web of Science ®Google Scholar
• Agerup B, Berg P, Akermark C. Non-animal stabilized hyaluronic acid: a new formulation for the treatment of osteoarthritis. BioDrugs. 2005;19(1):23–30. doi:10.2165/00063030-200519010-0000315691214
   PubMed Web of Science ®Google Scholar